MRK vs PYPL: Which Is the Better Buy?
Side-by-side comparison of Merck & Co., Inc. and PayPal Holdings, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-18.
Merck & Co., Inc. · Healthcare
$147.17
-4.1% upside to fair value
Med Conviction
Grade C
VS
PayPal Holdings, Inc. · Financial Services
$52.71
+9.1% upside to fair value
Med Conviction
Grade B-
QuantHub Verdict
PYPL has more upside to fair value
(+9.1%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MRK |
PYPL |
| Current Price |
$147.17 |
$52.71 |
| Fair Value Estimate |
$141.07 |
$57.50 |
| Upside to Fair Value |
-4.1%
|
+9.1%
|
| Market Cap |
$363.5B |
$45.1B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
29.6x
|
6.8x
|
| Price / Sales |
5.5x
|
1.3x
|
| Price / FCF |
22.6x
|
7.2x
|
| Revenue Growth YoY |
+5.1%
|
+4.8%
|
| Gross Margin |
75.4%
|
45.8%
|
| Operating Margin |
16.7%
|
18.8%
|
| Return on Equity |
6.6%
|
24.4%
|
| Dividend Yield |
2.31% |
1.06% |
| FCF Yield |
4.42%
|
13.97%
|
| Analyst Consensus |
Buy
|
Hold
|
Investment Thesis
Merck & Co., Inc. is a global healthcare leader with two core divisions, Pharmaceuticals and Animal Health, spanning oncology, vaccines, acute hospital care, immunology, neuroscience, virology, cardiovascular and diabetes, and it employs roughly 74,000 people under CEO Robert Davis. The business quality is medium: TTM gross margin of 75.4% and TTM operating margin of 16.7% reflect a genuinely hig…
PayPal operates a global digital-payments platform spanning branded checkout, Venmo, Braintree merchant processing, credit products and fraud-risk infrastructure across approximately 200 markets. Business quality is medium: its two-sided network, trusted brand, broad merchant distribution and risk capabilities remain meaningful assets, but its highest-value branded-checkout franchise is under com…
Accumulation Zones
| Metric |
MRK |
PYPL |
| Zone Low |
$105.80 |
$43.12 |
| Zone High |
$119.91 |
$48.88 |
| In Buy Zone? |
No
|
No
|